SD BioLife Sciences Completes General Public Offering of Forfeited Shares with Subscription Competition Rate of 399.08 to 1

[Asia Economy Reporter Jang Hyowon] SD Bioscience, a company specializing in the manufacturing and sales of cosmetics and health supplements, announced that it has completed the general public subscription following a rights offering conducted for existing shareholders.

SD Bioscience disclosed on the 19th that the general public subscription for 999,594 forfeited shares was held from the 17th to 18th, resulting in 267,691,038 shares subscribed, reaching a subscription rate of 1503.64% including the rights offering subscription by existing shareholders.

In June, SD Bioscience completed and began full operation of its second health supplement manufacturing plant in the Wonnam Industrial Complex, Eumseong, Chungbuk, and is currently pursuing technical partnerships and business agreements related to health supplement manufacturing with various manufacturers and distributors.

A company representative stated, “Following the high subscription rate in the rights offering for existing shareholders, the general public subscription also exceeded expectations with a competition rate of 399.08 to 1, achieving oversubscription without forfeited shares. Through successful fundraising, we will focus on ongoing individually recognized R&D, health supplement, and cosmetics businesses based on stabilized finances.”

Meanwhile, the funds raised through this rights offering will be paid on October 20, and the listing date of the new shares is November 3.

This content was produced with the assistance of AI translation services.